$NanoString Technologies(NSTGQ.US)$Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of solutions for spatial transcriptomics and gene expression analysis. Under the asset purchase agreement, Bruker expects to acquire substantially all of the assets and rights associated with NanoString's business, including the nCounter(R) , GeoMx(R) , C...
NanoString Technologies股票討論區
Under the asset purchase agreement, Bruker expects to acquire substantially all of the assets and rights associated with NanoString's business, including the nCounter(R) , GeoMx(R) , C...
$BiomX(PHGE.US)$ $Larimar Therapeutics(LRMR.US)$ $Clene(CLNN.US)$ $Glucotrack(GCTK.US)$ $Sonnet BioTherapeutic(SONN.US)$ $FibroBiologics(FBLG.US)$ $NanoString Technologies(NSTGQ.US)$
📊⚡️📊
暫無評論